Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury
Authors:
- Christine U. VohwinkelCVChristine U. Vohwinkel
- Yasmin BuchäckertYBYasmin Buchäckert
- Hamza M. Al-TamariHAHamza M. Al-Tamari
- Luciana C. MazzocchiLMLuciana C. Mazzocchi
- Holger K. EltzschigHEHolger K. Eltzschig
- Konstantin MayerKMKonstantin Mayer
- Rory E. MortyRMRory E. Morty
- Susanne HeroldSHSusanne Herold
- Werner SeegerWSWerner Seeger
- Soni S. PullamsettiSPSoni S. Pullamsetti
- István VadászIVIstván Vadász
- 1 November 2017
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 57 (5) , 589-602
Abstract
Acute respiratory distress syndrome constitutes a significant disease burden with regard to both morbidity and mortality. Current therapies are mostly supportive and do not address the underlying pathophysiologic mechanisms. Removal of protein-rich alveolar edema—a clinical hallmark of acute respiratory distress syndrome—is critical for survival. Here, we describe a transforming growth factor (TGF)-β–triggered mechanism, in which megalin, the primary mediator of alveolar protein transport, is negatively regulated by glycogen synthase kinase (GSK) 3β, with protein phosphatase 1 and nuclear inhibitor of protein phosphatase 1 being involved in the signaling cascade. Inhibition of GSK3β rescued transepithelial protein clearance in primary alveolar epithelial cells after TGF-β treatment. Moreover, in a bleomycin-based model of acute lung injury, megalin+/– animals (the megalin–/– variant is lethal due to postnatal respiratory failure) showed a marked increase in intra-alveolar protein and more severe lung injury compared with wild-type littermates. In contrast, wild-type mice treated with the clinically relevant GSK3β inhibitors, tideglusib and valproate, exhibited significantly decreased alveolar protein concentrations, which was associated with improved lung function and histopathology. Together, we discovered that the TGF-β–GSK3β–megalin axis is centrally involved in disturbances of alveolar protein clearance in acute lung injury and provide preclinical evidence for therapeutic efficacy of GSK3β inhibition.Keywords
This publication has 60 references indexed in Scilit:
- The acute respiratory distress syndromeJournal of Clinical Investigation, 2012
- Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary HypertensionPLOS ONE, 2011
- The extended PP1 toolkit: designed to create specificityTrends in Biochemical Sciences, 2010
- GSK3: a multifaceted kinase in Wnt signalingTrends in Biochemical Sciences, 2010
- Glycogen synthase kinase 3: more than a namesakeBritish Journal of Pharmacology, 2009
- Animal models of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Regulation of alveolar epithelial function by hypoxiaEuropean Respiratory Journal, 2008
- AMP-activated protein kinase regulates CO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosisJournal of Clinical Investigation, 2008
- NIPP1-mediated Interaction of Protein Phosphatase-1 with CDC5L, a Regulator of Pre-mRNA Splicing and Mitotic EntryJournal of Biological Chemistry, 2000
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995